(Q34445845)

2 August 2017

TET1 is a tumour suppressor that inhibits colon cancer growth by derepressing inhibitors of the WNT pathway (English)

1 reference

2 August 2017

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25362856%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Panagiotis Paliogiannis

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25362856%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Salvatore Oliviero

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25362856%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

author name string

D Dettori

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25362856%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

D Incarnato

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25362856%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

A Krepelova

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25362856%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

S Rapelli

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25362856%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

M Maldotti

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25362856%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

C Parlato

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25362856%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

language of work or name

English

0 references

publication date

3 November 2014

1 reference

2 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25362856%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25362856%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

page(s)

4168-4176

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25362856%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

issue

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25362856%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/onc.2014.356

7 June 2020

exact match

0 references

cites work

DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.356

DNA methylation: roles in mammalian development

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.356

Dnmt3L antagonizes DNA methylation at bivalent promoters and favors DNA methylation at gene bodies in ESCs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.356

The DNA methyltransferases of mammals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.356

Identification of genetic elements that autonomously determine DNA methylation states.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.356

Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.356

DNA methylation and cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.356

Integrated analysis of genome-wide DNA methylation and gene expression profiles in molecular subtypes of breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.356

A DNA hypermethylation module for the stem/progenitor cell signature of cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.356

DNMT1 and DNMT3b cooperate to silence genes in human cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.356

Targeted methylation of two tumor suppressor genes is sufficient to transform mesenchymal stem cells into cancer stem/initiating cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.356

Induction of Tumors in Mice by Genomic Hypomethylation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.356

Predicting aberrant CpG island methylation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.356

Frequent epigenetic inactivation of DICKKOPF family genes in human gastrointestinal tumors.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.356

Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.356

DNMT1 and DNMT3B modulate distinct polycomb-mediated histone modifications in colon cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.356

Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.356

Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.356

Thymine DNA glycosylase can rapidly excise 5-formylcytosine and 5-carboxylcytosine: potential implications for active demethylation of CpG sites

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.356

Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.356

Genome-wide analysis identifies a functional association of Tet1 and Polycomb repressive complex 2 in mouse embryonic stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.356

Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.356

Loss of 5-hydroxymethylcytosine is accompanied with malignant cellular transformation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.356

Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.356

Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.356

Mutations of the TET2 and CBL genes: novel molecular markers in myeloid malignancies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.356

Tet2 facilitates the derepression of myeloid target genes during CEBPα-induced transdifferentiation of pre-B cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.356

Metabolism unhinged: IDH mutations in cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.356

5-Hydroxymethylcytosine is strongly depleted in human cancers but its levels do not correlate with IDH1 mutations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.356

MicroRNA-antagonism regulates breast cancer stemness and metastasis via TET-family-dependent chromatin remodeling.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.356

TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.356

TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.356

Analysis of the ten-eleven translocation 2 (TET2) gene in familial myeloproliferative neoplasms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.356

HMGA2/TET1/HOXA9 signaling pathway regulates breast cancer growth and metastasis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.356

TET1 suppresses cancer invasion by activating the tissue inhibitors of metalloproteinases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.356

The Wnt/beta-catenin pathway regulates growth and maintenance of colonospheres

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.356

Widespread plasticity in CTCF occupancy linked to DNA methylation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.356

Ontogeny, distribution and potential roles of 5-hydroxymethylcytosine in human liver function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.356

5-hydroxymethylcytosine and its potential roles in development and cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.356

Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.356

MREdictor: a two-step dynamic interaction model that accounts for mRNA accessibility and Pumilio binding accurately predicts microRNA targets

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.356

TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.356

Differential analysis of gene regulation at transcript resolution with RNA-seq

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.356

FOSL1 controls the assembly of endothelial cells into capillary tubes by direct repression of αv and β3 integrin transcription

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.356

Myc and max genome-wide binding sites analysis links the Myc regulatory network with the polycomb and the core pluripotency networks in mouse embryonic stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.356

Myc regulates the transcription of the PRC2 gene to control the expression of developmental genes in embryonic stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.356

Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.356

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.356

The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to promote hematopoietic stem cell self-renewal and transformation

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25362856